InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by MILNE GEORGE M JR, Director. Director active across 4 companies, notably CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Aggregated, 5 reports have been logged. Total volume traded: €933k. The latest transaction was filed on 4 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€48,8855,000 shares@ €9.7770.0023% mcap100.0% of flow
Common Stock
SEC:0001628280-22-005381:0·
Ideal exit: 29 Nov 2022 (T+270)
€441,93726,315 shares@ €16.7941100.0% of flow
Common Stock
SEC:0000899243-22-001521·
Ideal exit: 3 Oct 2022 (T+270)
€441,93726,315 shares@ €16.79410.030% mcap50.0% of flow
Common Stock
SEC:0000899243-22-001521:0·
Ideal exit: 3 Oct 2022 (T+270)
0355 shares0
Common Stock
SEC:0001127602-21-016113·
0355 shares0
Common Stock
SEC:0001127602-21-016113:0·
5 of 5 declarations
About MILNE GEORGE M JR
George M. Milne Jr. is a Director at Charles River Laboratories International, Inc. and Amylyx Pharmaceuticals, Inc. In this role, he participates in the governance and strategic direction of these companies. George brings his expertise to help guide decisions that support the mission and objectives of Charles River and Amylyx.
